US Patent Family Members and Approved Drugs for South Korea Patent: 100486373
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for South Korea Patent: KR100486373
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 6,074,372 | 2044-05-16 | insulin human | Novo Nordisk Inc. | NOVOLIN R |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
